Posts by Admin BioAlps
iOnctura announces €80 Million Series B
iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, announced that it has closed an €80 Million Series B financing. The funding round was led by new investor Syncona Limited with participation by the EIC Fund, the venture arm of the European Innovation Council (EIC), as well as existing investors M Ventures, Inkef Capital,…
Read MoreHekeTiss gets CHF 100’000 seed loan from FONGIT Innovation Fund (FIF)
The FONGIT Innovation Fund (FIF) in Geneva has awarded new funding to three cutting-edge tech projects including HekeTiss. UNIGE and HUG spinoff HekeTiss, an award-winning startup, has secured a Seed Loan of CHF 100’000, building on their previous FIF Grant of CHF 50,000 awarded in 2022. HekeTiss has developed trophiPatch, an innovative treatment…
Read MoreiOnctura partners with the Dutch Cancer Society
iOnctura announced that they have been awarded funding from the KWF Kankerbestrijding / Dutch Cancer Society to further the development of IOA-289 for fibrotic tumours. This project focuses on a new drug for cancers with high levels of connective tissue formation, such as pancreatic cancer. The aim is to inhibit ‘bad’ connective tissue…
Read MoreMedFIT
BioFIT is the leading European partnering event for early-stage deals and investment rounds in the Life Sciences field.
Read MoreCalypso enters into agreement to be acquired by Novartis
Calypso’s shareholders will receive an upfront payment of $250 Million upon closing and are eligible to receive up to $175 Million based on the achievement of certain predetermined milestones. Calypso is a leader in the development of Interleukin15 (IL-15) targeted therapies. Calypso, a spin-out from Merck based in Plan-Les-Ouates (Geneva), is focused on…
Read MoreTimeline raises CHF56 Million and partners with L’Oréal
Already backed by Nestlé, the Swiss Health Valley startup co-founded by former EPFL President Patrick Aebischer, now counts a second leading multinational among its investors: L’Oréal. The fact that L’Oréal is investing in Timeline, a pioneering longevity brand, demonstrates the cosmetics giant’s interest in this fast-growing trend,” says Chris Rinsch, co-founder of the…
Read MoreDebiotech launches its engineering house
New year, new challenges! Debiotech, a leader in medical technologies based in Lausanne – Switzerland, announces the launch of its Engineering’s House as part of the strategic pivot initiated at the end of 2021. The aim is to continue supporting medical innovation by making its engineering expertise and proven regulatory methodology available to its customers…
Read MoreTune Insight leads a €1.8 Million project for data collaboration in paediatric emergency units
The EPFL spin-off has created a technology able to move past privacy and security issues for data sharing. The project, funded by the Eurostars programme, will involve paediatric units in hospitals in Italy and Switzerland. Along with Italian and Swiss hospitals from the paediatric emergency research network (PERN), including Insel GruppeSpital in Bern,…
Read MoreStalicla Secures $17.4 Million in Series B Financing
The Geneva-based clinical-stage biopharmaceutical company is advancing precision medicine pipelines for neuropsychiatric and neurological disorders STALICLA announces the successful completion of the first closing of its Series B financing round, securing $17.4 million. Led by SPRIM Global Investments Pte, Ltd, with key participation from core investors, this funding includes a $3.8 million credit…
Read MoreSocorex wins the CSEM Digital Health Journey Award
This SME based in Ecublens (VD), is a world leader in development and manufacture of high-end precision dosing instruments for liquid handling in laboratories and animal health injections. The award, valued at CHF 100,000, will help the company develop a new solution with a strong environmental impact. The company specializes in the development…
Read More